Back to Search
Start Over
What do the Universal Test and Treat Trials tell us about the path to HIV epidemic control?
- Source :
- Journal of the International AIDS Society, Journal of the International AIDS Society, 2020, Journal of the International AIDS Society, 23 (2), ⟨10.1002/jia2.25455⟩, Journal of the International AIDS Society, BioMed Central (2008-2012) ; International Aids Society (2008-) ; Wiley (2017-), 2020, Journal of the International AIDS Society, 23 (2), ⟨10.1002/jia2.25455⟩
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- Author(s): Havlir, Diane; Lockman, Shahin; Ayles, Helen; Larmarange, Joseph; Chamie, Gabriel; Gaolathe, Tendani; Iwuji, Collins; Fidler, Sarah; Kamya, Moses; Floyd, Sian; Moore, Janet; Hayes, Richard; Petersen, Maya; Dabis, Francois; (Universal Test, Treat Trials) UT3 Consortium | Abstract: IntroductionAchieving HIV epidemic control globally will require new strategies to accelerate reductions in HIV incidence and mortality. Universal test and treat (UTT) was evaluated in four randomized population-based trials (BCPP/Ya Tsie, HPTN 071/PopART, SEARCH, ANRS 12249/TasP) conducted in sub-Saharan African(SSA) during expanded antiretroviral treatment (ART) eligibility by World Health Organization guidelines and the UNAIDS 90-90-90 campaign.DiscussionThese three-year studies were conducted in Botswana, Zambia, Uganda, Kenya and South Africa in settings with baseline HIV prevalence from 4% to 30%. Key observations across studies were: (1) Universal testing (implemented via a variety of home and community-based testing approaches) achieved g90% coverage in all studies. (2) When coupled with robust linkage to HIV care, rapid ART start and patient-centred care, UTT achieved among the highest reported population levels of viral suppression in SSA. Significant gains in population-level viral suppression were made in regions with both low and high baseline population viral load; however, viral suppression gains were not uniform across all sub-populations and were lower among youth. (3) UTT resulted innmarked reductions in community HIV incidence when universal testing and robust linkage were present. However, HIV elimination targets were not reached. In BCPP and HPTN 071, annualized HIV incidence was approximately 20% to 30% lower in the intervention (which included universal testing) compared to control arms (no universal testing). In SEARCH (where both arms had universal testing), incidence declined 32% over three years. (4) UTT reduced HIV associated mortality by 23% in the intervention versus control communities in SEARCH, a study in whichnmortality was comprehensively measured.ConclusionsThese trials provide strong evidence that UTT inclusive of universal testing increases population-level viral suppression and decreases HIV incidence and mortality faster than the status quo in SSA and should be adapted at a sub-country level as a public health strategy. However, more is needed, including integration of new prevention interventions into UTT, in order to reach UNAIDS HIV elimination targets.
- Subjects :
- Male
ZAMBIE
HIV elimination
Hiv epidemic
Psychological intervention
HIV Infections
universal access
INITIATION
South Africa
0302 clinical medicine
OUGANDA
INFECTION
AFRIQUE SUBSAHARIENNE
Prevalence
Medicine
Mass Screening
Uganda
030212 general & internal medicine
education.field_of_study
Botswana
Incidence (epidemiology)
Incidence
public health
AIDS Serodiagnosis
Viral Load
3. Good health
HIV testing
Infectious Diseases
Female
0305 other medical science
Viral load
Life Sciences & Biomedicine
052
050
056
AFRICA
Adult
medicine.medical_specialty
Adolescent
Anti-HIV Agents
Population
Immunology
antiretroviral therapy
HIV prevention
Zambia
World health
Time-to-Treatment
1117 Public Health and Health Services
IDLIC
03 medical and health sciences
HIV care continuum
Humans
education
Epidemics
AFRIQUE DU SUD
030505 public health
Science & Technology
business.industry
Public health
Public Health, Environmental and Occupational Health
1103 Clinical Sciences
Kenya
(Universal Test, Treat Trials) UT3 Consortium
Test and treat
Commentary
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
business
Demography
1199 Other Medical and Health Sciences
Subjects
Details
- Language :
- English
- ISSN :
- 17582652
- Database :
- OpenAIRE
- Journal :
- Journal of the International AIDS Society, Journal of the International AIDS Society, 2020, Journal of the International AIDS Society, 23 (2), ⟨10.1002/jia2.25455⟩, Journal of the International AIDS Society, BioMed Central (2008-2012) ; International Aids Society (2008-) ; Wiley (2017-), 2020, Journal of the International AIDS Society, 23 (2), ⟨10.1002/jia2.25455⟩
- Accession number :
- edsair.doi.dedup.....b74a5abbfa71ced4976c1c74dc8fbc1d
- Full Text :
- https://doi.org/10.1002/jia2.25455⟩